Chemical Compound
(+)-trans-anti-BPDE-N2-dG
CAS Registry Number
65437-20-9
Primary Record
(+)-trans-anti-BPDE-N2-dG
Note: Only for scientific research or as raw materials for production.
- In stock
- 8,600 g
- Purity
- 98.5 %
- CAS
- 65437-20-9
Compound Identifiers & Properties
- CAS
- 65437-20-9
- PubChem CID
- 135625228
- SMILES
- C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2N=C(NC3=O)N[C@@H]4[C@H]([C@H]([C@@H](C5=C4C6=C7C(=C5)C=CC8=C7C(=CC=C8)C=C6)O)O)O)CO)O
- Canonical SMILES
- O=c1[nH]c(N[C@H]2c3c(cc4ccc5cccc6ccc3c4c56)[C@@H](O)[C@H](O)[C@@H]2O)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1
Names & Synonyms
- (+)-trans-anti-BPDE-N2-dG
- AC1L3OY5
- (+)-trans-B[a]P-N2-dG
- (+)_trans-anti-Benzo(a)pyrene-dG
- WOKFWJGVLJVTLH-KCAXFQNZSA-N
- (+)-trans-anti-Benzo[a]pyrene-dG
- AR-1E1169
- CID119514
- 10S(+)-trans-anti-[BP]-N2-dG
- C30-H27-N5-O7
- N2-Benzo(a)pyrene-triol-deoxyguanosine
- 65437-20-9
- J431.053E
- 10S(+)-trans-anti-Benzo[a]pyrene-N2-deoxyguanosine
- 9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-[[(7R,8S,9R,10S)-7,8,9-trihydroxy-7,8,9,10-tetrahydrobenzo[a]pyren-10-yl]amino]-3H-purin-6-one
- 2'-Deoxy-N-((7R,8S,9R,10S)-7,8,9,10-tetrahydro-7,8,9,trihydroxybenzo(a)pyrene-10-yl)quanosine
- 9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-[[(7R,8S,9R,10S)-7,8,9-trihydroxy-7,8,9,10-tetrahydrobenzo[a]pyren-10-yl]amino]-1H-purin-6-one
- Guanosine, 2'-deoxy-N-((7R,8S,9R,10S)-7,8,9,10-tetrahydro-7,8,9,trihydroxybenzo(a)pyrene-10-yl)-
- Guanosine, 2'-deoxy-N-(7,8,9,10-tetrahydro-7,8,9-trihydroxybenzo(a)pyren-10-yl)-
- (+)-trans-anti-Benzo[a]pyrene-dG; 10S(+)-trans-anti-[Py]-N2-dG; [7R-(7a,8ss,9ss,10a)]-2'-deoxy-N-(7,8,9,10-tetrahydro-7,8,9-trihydroxybenzo[a]pyren-10-yl)guanosine; Benzo[a]pyrene, guanosine deriv.; (+)-r-7,t-8-Dihydroxy-t-9,10-oxy-7,8,9,10-tetrahydrobenzo[a]pyrene-dG; (+)-trans-anti-7,8,9-Trihydroxy-10-(2'-deoxyguanosin-2-yl)benzo[a]pyrene
- 2 -Deoxy-N-[[(7R)-7beta,8alpha,9alpha-trihydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene]-10beta-yl]guanosine
- 2'-Deoxy-N-[(7R,8S,9R,10S)-7,8,9,10-tetrahydro-7,8,9-trihydroxybenzo[a]pyren-10-yl]Guanosine
- 2'-deoxy-n-[(7r,8s,9r,10s)-7,8,9-trihydroxy-7,8,9,10-tetrahydrobenzo[pqr]tetraphen-10-yl]guanosine
- 2'-Deoxy-N-[[rel-(7R,8S,9R,S)]-7,8,9,-tetrahydro-7,8,9-trihydroxybenzo[a]pyren--yl]guanosine
- 2-[(7beta,8alpha,9alpha-Trihydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene-10beta-yl)amino]-9-(2-deoxy-beta-D-erythro-pentofuranosyl)-1H-purine-6(9H)-one
- 67874-25-3
- 9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-{[(3S,4R,5S,6R)-4,5,6-trihydroxypentacyclo[10.6.2.02,7.09,19.016,20]icosa-1,7,9,11,13,15,17,19-octaen-3-yl]amino}-6,9-dihydro-1H-purin-6-one
- 92842-72-3
- N-(7,8,9,10-Tetrahydro-7beta,8alpha,9alpha-trihydroxybenzo[a]pyrene-10beta-yl)-2 -deoxyguanosine
- N-(7beta,8alpha,9alpha-Trihydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene-10beta-yl)-2 -deoxyguanosine
- N-[(10S)-7beta,8alpha,9alpha-Trihydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene-10beta-yl]-2 -deoxyguanosine
- N-[(7R)-7,8,9,10-Tetrahydro-7beta,8alpha,9alpha-trihydroxybenzo[a]pyrene-10beta-yl]-2 -deoxyguanosine
- N-[(7R)-7beta,8alpha,9alpha-Trihydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene-10beta-yl]-2 -deoxyguanosine
- N-[(7R)-7beta,8alpha,9alpha-Trihydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene-10beta-yl]2 -deoxyguanosine
- N-[(7R,8S,9R,10S)-7,8,9,10-Tetrahydro-7,8,9-trihydroxybenzo[a]pyrene-10-yl]-2 -deoxyguanosine
- N-[(7R,8S,9R,10S)-7,8,9,10-Tetrahydro-7beta,8alpha,9alpha-trihydroxybenzo[a]pyrene-10beta-yl]-2 -deoxyguanosine
- N-[(7R,8S,9R,10S)-7,8,9-Trihydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene-10-yl]-2 -deoxyguanosine
- N-[[(7R)-7,8,9,10-Tetrahydro-7beta,8alpha,9alpha-trihydroxybenzo[a]pyren]-10beta-yl]-2 -deoxyguanosine
- N-[7beta,8alpha,9alpha-Trihydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene-10beta-yl]-2 -deoxyguanosine